Organogenesis Holdings Inc.
ORGO
$4.97
$0.1453.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 429.31M | 458.76M | 482.04M | 455.04M | 448.39M |
| Total Other Revenue | 226.00K | -- | -- | -- | -- |
| Total Revenue | 429.53M | 458.76M | 482.04M | 455.04M | 448.39M |
| Cost of Revenue | 109.20M | 110.77M | 115.74M | 112.46M | 111.45M |
| Gross Profit | 320.33M | 347.99M | 366.30M | 342.58M | 336.94M |
| SG&A Expenses | 291.97M | 294.70M | 294.51M | 280.12M | 272.45M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 444.08M | 453.57M | 460.53M | 443.09M | 434.54M |
| Operating Income | -14.55M | 5.19M | 21.52M | 11.95M | 13.85M |
| Income Before Tax | -21.54M | -24.25M | -2.81M | -14.86M | -13.04M |
| Income Tax Expenses | -13.31M | -8.37M | -3.67M | -7.48M | 3.50M |
| Earnings from Continuing Operations | -8.23 | -15.88 | 0.86 | -7.38 | -16.54 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.23M | -15.88M | 861.00K | -7.38M | -16.54M |
| EBIT | -14.55M | 5.19M | 21.52M | 11.95M | 13.85M |
| EBITDA | 3.17M | 22.53M | 38.54M | 28.74M | 30.01M |
| EPS Basic | -0.13 | -0.16 | -0.01 | -0.06 | -0.12 |
| Normalized Basic EPS | -0.07 | 0.02 | 0.10 | 0.05 | 0.06 |
| EPS Diluted | -0.14 | -0.17 | -0.02 | -0.06 | -0.13 |
| Normalized Diluted EPS | -0.07 | 0.02 | 0.09 | 0.05 | 0.06 |
| Average Basic Shares Outstanding | 515.40M | 521.12M | 526.69M | 527.93M | 526.66M |
| Average Diluted Shares Outstanding | 519.24M | 524.96M | 530.52M | 530.22M | 529.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |